| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Ofranergene obadenovec | GT-111; VB-111 | Phase 3 Clinical | Vascular Pharmaceuticals Inc | Colorectal Neoplasms; Glioblastoma; Neoplasms; Neuroendocrine Tumors; Ovarian Neoplasms; Thyroid Carcinoma, Anaplastic | Details |
| Atrosab | Phase 1 Clinical | Celonic | Inflammation | Details |

